APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vaccine Testing Service Market Analysis and Forecast 2026-2032

12 April 2026255 pages

Choose your research edition.

Industry ResearchVaccine Testing Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Testing Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Vaccine Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Vaccine Testing Service Market Analysis and Forecast 2026-2032255 pages · $4,950 USD

Market perspective

The global Vaccine Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Vaccine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vaccine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vaccine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vaccine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Vaccine Testing Service include RSSL, Labcorp Drug Development, Charles River Laboratories, PPD, WuXi Biologics, Valneva, IQVIA Laboratories Vaccines, Minaris Advanced Testing and IntoxLab, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Vaccine Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vaccine Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Vaccine Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccine Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vaccine Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Vaccine Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Vaccine Testing Service Segment by Company

RSSL

Labcorp Drug Development

Charles River Laboratories

PPD

WuXi Biologics

Valneva

IQVIA Laboratories Vaccines

Minaris Advanced Testing

IntoxLab

Creative Diagnostics

Vaccine Testing Service Segment by Type

Physical and Chemical Testing

Microbial Detection

Immunological Testing

Others

Vaccine Testing Service Segment by Application

Inactivated Vaccine

Subunit Vaccine

Toxoid Vaccine

mRNA Vaccine

Viral Vector Vaccine

Others

Vaccine Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Vaccine Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Vaccine Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccine Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Physical and Chemical Testing Major Player Table 3. Microbial Detection Major Player Table 4. Immunological Testing Major Player Table 5. Others Major Player Table 6. Global Vaccine Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Inactivated Vaccine Major Player Table 8. Subunit Vaccine Major Player Table 9. Toxoid Vaccine Major Player Table 10. mRNA Vaccine Major Player Table 11. Viral Vector Vaccine Major Player Table 12. Others Major Player Table 13. Vaccine Testing Service Industry Trends Table 14. Vaccine Testing Service Industry Drivers Table 15. Vaccine Testing Service Industry Opportunities and Challenges Table 16. Vaccine Testing Service Industry Restraints Table 17. Global Vaccine Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Vaccine Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Vaccine Testing Service Market Share by Region (2021-2026) Table 20. Global Vaccine Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Vaccine Testing Service Market Share by Region (2027-2032) Table 22. Global Vaccine Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Vaccine Testing Service Revenue Market Share by Players (2021-2026) Table 24. Global Vaccine Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Vaccine Testing Service Key Players Headquarters & Area Served Table 26. Global Vaccine Testing Service Players, Product Type & Application Table 27. Global Vaccine Testing Service Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Vaccine Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Vaccine Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Vaccine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Vaccine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Vaccine Testing Service Revenue Market Share by Type (2021-2026) Table 34. Global Vaccine Testing Service Revenue Market Share by Type (2027-2032) Table 35. Global Vaccine Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Vaccine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Vaccine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Vaccine Testing Service Revenue Market Share by Application (2021-2026) Table 39. Global Vaccine Testing Service Revenue Market Share by Application (2027-2032) Table 40. RSSL Company Information Table 41. RSSL Business Overview Table 42. RSSL Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. RSSL Vaccine Testing Service Product Portfolio Table 44. RSSL Recent Development Table 45. Labcorp Drug Development Company Information Table 46. Labcorp Drug Development Business Overview Table 47. Labcorp Drug Development Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Labcorp Drug Development Vaccine Testing Service Product Portfolio Table 49. Labcorp Drug Development Recent Development Table 50. Charles River Laboratories Company Information Table 51. Charles River Laboratories Business Overview Table 52. Charles River Laboratories Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Charles River Laboratories Vaccine Testing Service Product Portfolio Table 54. Charles River Laboratories Recent Development Table 55. PPD Company Information Table 56. PPD Business Overview Table 57. PPD Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. PPD Vaccine Testing Service Product Portfolio Table 59. PPD Recent Development Table 60. WuXi Biologics Company Information Table 61. WuXi Biologics Business Overview Table 62. WuXi Biologics Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. WuXi Biologics Vaccine Testing Service Product Portfolio Table 64. WuXi Biologics Recent Development Table 65. Valneva Company Information Table 66. Valneva Business Overview Table 67. Valneva Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Valneva Vaccine Testing Service Product Portfolio Table 69. Valneva Recent Development Table 70. IQVIA Laboratories Vaccines Company Information Table 71. IQVIA Laboratories Vaccines Business Overview Table 72. IQVIA Laboratories Vaccines Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. IQVIA Laboratories Vaccines Vaccine Testing Service Product Portfolio Table 74. IQVIA Laboratories Vaccines Recent Development Table 75. Minaris Advanced Testing Company Information Table 76. Minaris Advanced Testing Business Overview Table 77. Minaris Advanced Testing Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Minaris Advanced Testing Vaccine Testing Service Product Portfolio Table 79. Minaris Advanced Testing Recent Development Table 80. IntoxLab Company Information Table 81. IntoxLab Business Overview Table 82. IntoxLab Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. IntoxLab Vaccine Testing Service Product Portfolio Table 84. IntoxLab Recent Development Table 85. Creative Diagnostics Company Information Table 86. Creative Diagnostics Business Overview Table 87. Creative Diagnostics Vaccine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Creative Diagnostics Vaccine Testing Service Product Portfolio Table 89. Creative Diagnostics Recent Development Table 90. North America Vaccine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Vaccine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Vaccine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Vaccine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Vaccine Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Vaccine Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Vaccine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Vaccine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Vaccine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Vaccine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Vaccine Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Vaccine Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 104. China Vaccine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 105. China Vaccine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 106. China Vaccine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 107. China Vaccine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Vaccine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Vaccine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Vaccine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Vaccine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Vaccine Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Vaccine Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Vaccine Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Vaccine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Vaccine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Vaccine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Vaccine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Vaccine Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Vaccine Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Vaccine Testing Service Image Figure 2. Global Vaccine Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Physical and Chemical Testing Image Figure 5. Microbial Detection Image Figure 6. Immunological Testing Image Figure 7. Others Image Figure 8. Global Vaccine Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Vaccine Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Inactivated Vaccine Image Figure 11. Subunit Vaccine Image Figure 12. Toxoid Vaccine Image Figure 13. mRNA Vaccine Image Figure 14. Viral Vector Vaccine Image Figure 15. Others Image Figure 16. Global Vaccine Testing Service Market Size (US$ Million) & (2021-2032) Figure 17. Global Vaccine Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Vaccine Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Vaccine Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Vaccine Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Vaccine Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Vaccine Testing Service Revenue Market Share by Type (2021-2032) Figure 24. Global Vaccine Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Vaccine Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Vaccine Testing Service Revenue Market Share by Application (2021-2032) Figure 27. North America Vaccine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Vaccine Testing Service Revenue Share by Type (2021-2032) Figure 29. North America Vaccine Testing Service Revenue Share by Application (2021-2032) Figure 30. North America Vaccine Testing Service Revenue Share by Country (2021-2032) Figure 31. United States Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Vaccine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Vaccine Testing Service Revenue Share by Type (2021-2032) Figure 36. Europe Vaccine Testing Service Revenue Share by Application (2021-2032) Figure 37. Europe Vaccine Testing Service Revenue Share by Country (2021-2032) Figure 38. Germany Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Vaccine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Vaccine Testing Service Revenue Share by Type (2021-2032) Figure 48. China Vaccine Testing Service Revenue Share by Application (2021-2032) Figure 49. Asia Vaccine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Vaccine Testing Service Revenue Share by Type (2021-2032) Figure 51. Asia Vaccine Testing Service Revenue Share by Application (2021-2032) Figure 52. Asia Vaccine Testing Service Revenue Share by Region (2021-2032) Figure 53. Japan Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Vaccine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Vaccine Testing Service Revenue Share by Type (2021-2032) Figure 61. SAMEA Vaccine Testing Service Revenue Share by Application (2021-2032) Figure 62. SAMEA Vaccine Testing Service Revenue Share by Country (2021-2032) Figure 63. Brazil Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Vaccine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Physical and Chemical Testing
  • Microbial Detection
  • Immunological Testing
  • Others
Applications
  • Inactivated Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • mRNA Vaccine
  • Viral Vector Vaccine
  • Others
Companies covered
  • RSSL
  • Labcorp Drug Development
  • Charles River Laboratories
  • PPD
  • WuXi Biologics
  • Valneva
  • IQVIA Laboratories Vaccines
  • Minaris Advanced Testing
  • IntoxLab
  • Creative Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vaccine Testing Service Market by Type
  3. 1.2.1 Global Vaccine Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Physical and Chemical Testing
  5. 1.2.3 Microbial Detection
  6. 1.2.4 Immunological Testing
  7. 1.2.5 Others
  8. 1.3 Vaccine Testing Service Market by Application
  9. 1.3.1 Global Vaccine Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Inactivated Vaccine
  11. 1.3.3 Subunit Vaccine
  12. 1.3.4 Toxoid Vaccine
  13. 1.3.5 mRNA Vaccine
  14. 1.3.6 Viral Vector Vaccine
  15. 1.3.7 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Vaccine Testing Service Market Dynamics
  1. 2.1 Vaccine Testing Service Industry Trends
  2. 2.2 Vaccine Testing Service Industry Drivers
  3. 2.3 Vaccine Testing Service Industry Opportunities and Challenges
  4. 2.4 Vaccine Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Vaccine Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Vaccine Testing Service Growth Trends by Region
  3. 3.2.1 Global Vaccine Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vaccine Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Vaccine Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Vaccine Testing Service Revenue by Players
  2. 4.1.1 Global Vaccine Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Vaccine Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Vaccine Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vaccine Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Vaccine Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Vaccine Testing Service Players, Product Type & Application
  8. 4.5 Global Vaccine Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Vaccine Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Vaccine Testing Service Tier 1, Tier 2, and Tier 3
5 Vaccine Testing Service Market Size by Type
  1. 5.1 Global Vaccine Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Vaccine Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Vaccine Testing Service Revenue Market Share by Type (2021-2032)
6 Vaccine Testing Service Market Size by Application
  1. 6.1 Global Vaccine Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Vaccine Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Vaccine Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 RSSL
  2. 7.1.1 RSSL Company Information
  3. 7.1.2 RSSL Business Overview
  4. 7.1.3 RSSL Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 RSSL Vaccine Testing Service Product Portfolio
  6. 7.1.5 RSSL Recent Developments
  7. 7.2 Labcorp Drug Development
  8. 7.2.1 Labcorp Drug Development Company Information
  9. 7.2.2 Labcorp Drug Development Business Overview
  10. 7.2.3 Labcorp Drug Development Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Drug Development Vaccine Testing Service Product Portfolio
  12. 7.2.5 Labcorp Drug Development Recent Developments
  13. 7.3 Charles River Laboratories
  14. 7.3.1 Charles River Laboratories Company Information
  15. 7.3.2 Charles River Laboratories Business Overview
  16. 7.3.3 Charles River Laboratories Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Charles River Laboratories Vaccine Testing Service Product Portfolio
  18. 7.3.5 Charles River Laboratories Recent Developments
  19. 7.4 PPD
  20. 7.4.1 PPD Company Information
  21. 7.4.2 PPD Business Overview
  22. 7.4.3 PPD Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 PPD Vaccine Testing Service Product Portfolio
  24. 7.4.5 PPD Recent Developments
  25. 7.5 WuXi Biologics
  26. 7.5.1 WuXi Biologics Company Information
  27. 7.5.2 WuXi Biologics Business Overview
  28. 7.5.3 WuXi Biologics Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 WuXi Biologics Vaccine Testing Service Product Portfolio
  30. 7.5.5 WuXi Biologics Recent Developments
  31. 7.6 Valneva
  32. 7.6.1 Valneva Company Information
  33. 7.6.2 Valneva Business Overview
  34. 7.6.3 Valneva Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Valneva Vaccine Testing Service Product Portfolio
  36. 7.6.5 Valneva Recent Developments
  37. 7.7 IQVIA Laboratories Vaccines
  38. 7.7.1 IQVIA Laboratories Vaccines Company Information
  39. 7.7.2 IQVIA Laboratories Vaccines Business Overview
  40. 7.7.3 IQVIA Laboratories Vaccines Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 IQVIA Laboratories Vaccines Vaccine Testing Service Product Portfolio
  42. 7.7.5 IQVIA Laboratories Vaccines Recent Developments
  43. 7.8 Minaris Advanced Testing
  44. 7.8.1 Minaris Advanced Testing Company Information
  45. 7.8.2 Minaris Advanced Testing Business Overview
  46. 7.8.3 Minaris Advanced Testing Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Minaris Advanced Testing Vaccine Testing Service Product Portfolio
  48. 7.8.5 Minaris Advanced Testing Recent Developments
  49. 7.9 IntoxLab
  50. 7.9.1 IntoxLab Company Information
  51. 7.9.2 IntoxLab Business Overview
  52. 7.9.3 IntoxLab Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 IntoxLab Vaccine Testing Service Product Portfolio
  54. 7.9.5 IntoxLab Recent Developments
  55. 7.10 Creative Diagnostics
  56. 7.10.1 Creative Diagnostics Company Information
  57. 7.10.2 Creative Diagnostics Business Overview
  58. 7.10.3 Creative Diagnostics Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Diagnostics Vaccine Testing Service Product Portfolio
  60. 7.10.5 Creative Diagnostics Recent Developments
8 North America
  1. 8.1 North America Vaccine Testing Service Revenue (2021-2032)
  2. 8.2 North America Vaccine Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Vaccine Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Vaccine Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Vaccine Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Vaccine Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Vaccine Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Vaccine Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Vaccine Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Vaccine Testing Service Revenue by Country
  11. 8.6.1 North America Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Vaccine Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Vaccine Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Vaccine Testing Service Revenue (2021-2032)
  2. 9.2 Europe Vaccine Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Vaccine Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Vaccine Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Vaccine Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Vaccine Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Vaccine Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Vaccine Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Vaccine Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Vaccine Testing Service Revenue by Country
  11. 9.6.1 Europe Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Vaccine Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Vaccine Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Vaccine Testing Service Revenue (2021-2032)
  2. 10.2 China Vaccine Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Vaccine Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Vaccine Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Vaccine Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Vaccine Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Vaccine Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Vaccine Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Vaccine Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vaccine Testing Service Revenue (2021-2032)
  2. 11.2 Asia Vaccine Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Vaccine Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Vaccine Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Vaccine Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Vaccine Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Vaccine Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Vaccine Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Vaccine Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Vaccine Testing Service Revenue by Country
  11. 11.6.1 Asia Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Vaccine Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Vaccine Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vaccine Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Vaccine Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Vaccine Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Vaccine Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Vaccine Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Vaccine Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Vaccine Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Vaccine Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Vaccine Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Vaccine Testing Service Revenue by Country
  11. 12.6.1 SAMEA Vaccine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Vaccine Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Vaccine Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst